237 related articles for article (PubMed ID: 19851209)
41. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
Brustmann H
Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
[TBL] [Abstract][Full Text] [Related]
43. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
44. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
45. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
Kindelberger DW; Lee Y; Miron A; Hirsch MS; Feltmate C; Medeiros F; Callahan MJ; Garner EO; Gordon RW; Birch C; Berkowitz RS; Muto MG; Crum CP
Am J Surg Pathol; 2007 Feb; 31(2):161-9. PubMed ID: 17255760
[TBL] [Abstract][Full Text] [Related]
46. The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology.
Gokden N; Kemp SA; Gokden M
Diagn Cytopathol; 2008 Jul; 36(7):473-7. PubMed ID: 18528893
[TBL] [Abstract][Full Text] [Related]
47. Cyclooxygenase 2 expression in serous tumors of the ovary.
Singhal PK; Spiegel G; Driscoll D; Odunsi K; Lele S; Rodabaugh KJ
Int J Gynecol Pathol; 2005 Jan; 24(1):62-6. PubMed ID: 15626918
[TBL] [Abstract][Full Text] [Related]
48. Fine-needle aspiration cytology of metastatic ovarian carcinoma to the breast.
Raptis S; Kanbour AI; Dusenbery D; Kanbour-Shakir A
Diagn Cytopathol; 1996 Jul; 15(1):1-6. PubMed ID: 8807244
[TBL] [Abstract][Full Text] [Related]
49. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
[TBL] [Abstract][Full Text] [Related]
50. Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach.
Armes JE; Bowlay G; Lourie R; Venter DJ; Price G
Pathology; 2010; 42(6):534-9. PubMed ID: 20854071
[TBL] [Abstract][Full Text] [Related]
51. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?
Tong GX; Chiriboga L; Hamele-Bena D; Borczuk AC
Mod Pathol; 2007 Aug; 20(8):856-63. PubMed ID: 17529925
[TBL] [Abstract][Full Text] [Related]
52. PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.
Tung CS; Mok SC; Tsang YT; Zu Z; Song H; Liu J; Deavers MT; Malpica A; Wolf JK; Lu KH; Gershenson DM; Wong KK
Mod Pathol; 2009 Sep; 22(9):1243-50. PubMed ID: 19525924
[TBL] [Abstract][Full Text] [Related]
53. An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas.
Zhang Y; Garcia-Buitrago MT; Koru-Sengul T; Schuman S; Ganjei-Azar P
Int J Gynecol Pathol; 2013 Sep; 32(5):476-81. PubMed ID: 23896709
[TBL] [Abstract][Full Text] [Related]
54. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
Ramalingam P; Masand RP; Euscher ED; Malpica A
Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
[TBL] [Abstract][Full Text] [Related]
55. Expression of CK19 in invasive breast carcinomas of special histological types: implications for the use of one-step nucleic acid amplification.
Alvarenga CA; Paravidino PI; Alvarenga M; Dufloth R; Gomes M; Zeferino LC; Schmitt F
J Clin Pathol; 2011 Jun; 64(6):493-7. PubMed ID: 21427448
[TBL] [Abstract][Full Text] [Related]
56. The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast.
Lee AH; Paish EC; Marchio C; Sapino A; Schmitt FC; Ellis IO; Reis-Filho JS
Histopathology; 2007 Dec; 51(6):824-8. PubMed ID: 18042071
[TBL] [Abstract][Full Text] [Related]
57. Hepatocyte nuclear factor-1β is not a specific marker of clear cell carcinoma in serous effusions.
Davidson B
Cancer Cytopathol; 2014 Feb; 122(2):153-8. PubMed ID: 24115587
[TBL] [Abstract][Full Text] [Related]
58. PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: A comprehensive immunohistochemical study.
Zhai QJ; Ozcan A; Hamilton C; Shen SS; Coffey D; Krishnan B; Truong LD
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):323-32. PubMed ID: 20216401
[TBL] [Abstract][Full Text] [Related]
59. Serous papillary cystadenocarcinoma arising from autografted ovary of the abdominal wall.
Gong W; Cheng H; Yan Q; Huang G; Luo P; Wang Z
Int J Surg Pathol; 2010 Oct; 18(5):398-400. PubMed ID: 19147508
[TBL] [Abstract][Full Text] [Related]
60. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
Nonaka D; Chiriboga L; Soslow RA
Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
